Evaluation of two in vitro pharmacodynamic simulation models: Microfiltration versus centrifugation-filtration

International Journal of Antimicrobial Agents

Volumn 17, Issue 5, 2001, Pages 365-370

  Alou, L ^a   Sevillano, D ^a   Bugella, J H ^a   Fuentes, F ^a   Gomez Lus M L ^a   Prieto, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

In vitro activity; Pharmacodynamics; Simulation models

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; GENTAMICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CENTRIFUGATION; DRUG BLOOD LEVEL; ESCHERICHIA COLI; FILTRATION; HAEMOPHILUS INFLUENZAE; INTERMETHOD COMPARISON; MICROFILTRATION; MINIMUM INHIBITORY CONCENTRATION; MODEL; PHARMACODYNAMICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERUM; SIMULATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CENTRIFUGATION; FILTRATION; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL;

EID: 0035037149     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00299-0     Document Type: Article

References (19)

1. Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method
2. Improved efficacy with nonsimultaneous first doses of gentamicin and ceftazidime in vitro
3. Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in vitro dynamic model
4. Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model
5. Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in vitro model simulating serum pharmacokinetic parameters
6. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model
7. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae
8. Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models
9. Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae
10. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation
11. In vitro pharmacodynamic simulation of clavulanic acid concentrations on Staphylococcus aureus and Haemophilus influenzae β-lactamase activity
12. Efficacy of trovafloxacin in an in vitro pharmacodynamic simulation of an introabdominal infection
13. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function
14. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation
15. The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin
16. Oral bioequivalence of three oral ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 ml or 500 mg/5 ml suspension and the effect of food on the absorption of ciprofloxacin oral suspension
17. Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses
18. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing
19. Effects of low concentrations of antibiotics on bacterial ultrastructure, virulence and susceptibility to immunodefenses: clinical significance